The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Abaxis (NAS: ABAX) is expected to report Q3 earnings around Jan. 24. Here's what Wall Street wants to see: Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ...

Canaccord, which rates Abaxis Inc (NASDAQ: ABAX) Hold and isn't covering Heska Corp (NASDAQ: HSKA), has provided key takeaways from management meetings with both companies. Analyst Mark Massaro said ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: As ...

Abaxis (Nasdaq: ABAX) is expected to report Q4 earnings on April 25. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year quarter, average ...

UNION CITY, Calif., Oct. 31, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company has signed ...

Abaxis is in the final stages of testing a new software product it calls FUSE, Wood said, which is a web-based package that enables two-way data sharing between its instruments and vet ...

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less ...

Looking at the universe of stocks we cover at Dividend Channel, on 2/27/15, Abaxis, Inc. (NASD: ABAX), Teleflex Incorporated (NYSE: TFX), and Chemed Corp (NYSE: CHE) will all trade ex-dividend for ...

(Reuters) - Top animal health company Zoetis Inc (ZTS.N) will buy Abaxis Inc (ABAX.O) for $1.9 billion (£1.4 billion), looking to capture a bigger slice of the fast-growing market for diagnostics ...

Abaxis (ABAX) reported its second straight earnings miss on October 22 as revenue came in below expectations and profit margins contracted. Analysts revised their estimates meaningfully lower for both ...